#USA #South San Francisco #FDB #Gravimetric Module #IV Compounding

New Gravimetric Module: Elevating IV Compounding Safety

FDB (First Databank, Inc.), a trailblazer in drug knowledge resources, has recently unveiled its latest innovation: the Gravimetric Drug Density Module. This advanced feature is aimed at significantly improving the workflows involved in sterile medication compounding, particularly for high-risk and high-cost medications. Healthcare professionals now have access to a tool designed to bolster safety, accuracy, and efficiency in these critical processes.

What is the Gravimetric Drug Density Module?

The new module integrates seamlessly within the widely adopted FDB MedKnowledge® platform, creating a powerful resource for clinicians aiming to make well-informed medication decisions at the point of care. FDB MedKnowledge already hosts a wealth of drug information, unique identifiers, and pricing data, but the addition of the gravimetric module brings a new dimension to medication safety.

The module provides normalized drug density data corresponding to the National Drug Code (NDC) level, effectively supporting gravimetric verification during the preparation of infusion medications. This means that health systems can calculate the expected weight of compounded preparations and compare this with the actual measured values. This additional layer of validation promotes greater accuracy beyond traditional visual and volumetric checks—critical for oncological therapies where small dosage errors could have serious ramifications.

Evidence of Error Reduction

The significance of gravimetric preparation is underscored by clinical research, including a noteworthy study published in the American Journal of Health-System Pharmacy. This study highlighted that gravimetric verification techniques considerably enhanced the detection of compounding discrepancies, increasing error detection rates nearly 90-fold compared to traditional methods. When using conventional approaches, discrepancies were identified in less than 1% of preparations, while over 40% of gravimetric preparations revealed errors. Pharmacists participating in the study expressed confidence in gravimetric workflows as the safest and most precise method for producing compounded sterile products.

Addressing Safety and Workflow Challenges

Traditional methods of verifying intravenous (IV) compounding rely predominantly on visual inspections, which can be tedious and time-consuming. Pharmacists must garment themselves in full personal protective equipment and physically enter sterile areas to conduct checks, a process that can slow down operations considerably.

In contrast, gravimetric workflows facilitate verification using collected weight measures and images that can be accessed outside of the cleanroom. This enhances safety and allows pharmacy staff to identify discrepancies early, improving workflow and efficiency without compromising precision.

Furthermore, the FDB Gravimetric Drug Density Module offers meticulously curated and maintained drug density data, negating the need for health systems to source, calculate, or manage this information internally. By providing this essential data centrally, FDB simplifies implementation, ensuring consistent and reliable verification practices throughout pharmacy operations.

Flexibility and Integration Options

The Gravimetric Drug Density Module is available as a premium addition to FDB MedKnowledge or can be utilized as a standalone solution for organizations needing NDC-level density data, independent from a broader medication knowledge system. The initial implementation emphasizes injectable antineoplastic medications, with the potential for future expansion.

Not only does this launch signify FDB's commitment to enhancing medication safety, but it also aligns with healthcare organizations as they explore modernized pharmacy operations amidst increasing pressures on their workforce.

In conclusion, the introduction of the FDB Gravimetric Drug Density Module represents a crucial advancement in the safety and quality of sterile compounding. As stated by Chirag Patel, PharmD, MBA, director of product management at FDB, “Gravimetric verification signifies a pivotal evolution in how health systems approach safety and quality.” FDB continues to equip pharmacies with trusted, scalable solutions, empowering them to reduce manual tasks and strengthen safety protocols surrounding high-risk medications, ultimately fostering a more automated and dependable workflow.